Edition:
United States

Derma Sciences Inc (DSCI.OQ)

DSCI.OQ on NASDAQ Stock Exchange Capital Market

7.00USD
22 Feb 2017
Change (% chg)

$0.00 (+0.00%)
Prev Close
$7.00
Open
$7.00
Day's High
$7.03
Day's Low
$7.00
Volume
102,608
Avg. Vol
32,690
52-wk High
$7.05
52-wk Low
$2.93

Select another date:

Wed, Jan 25 2017

BRIEF-Integra Lifesciences starts tender offer to buy Derma Sciences

* Integra Lifesciences commences previously announced cash tender offer to acquire Derma Sciences, Inc. Source text for Eikon: Further company coverage:

BRIEF-Gardner Lewis Asset Management L.P. reports 7.7 pct stake in Derma Sciences - SEC filing

* Gardner Lewis Asset Management, L.P. Reports 7.7 percent stake in Derma Sciences Inc as of Jan 11, 2017 - SEC filing Source text: (http://bit.ly/2jQIOyE) Further company coverage: (Bengaluru Newsroom: +91 806 749 1136)

BRIEF-Comvita Limited says sold Medihoney brand and related intellectual property to Derma Sciences

* Sold its medihoney brand and related intellectual property and goodwill to its long term US partner Derma Sciences, Inc in a comprehensive transaction

BRIEF-Derma Sciences buys Medihoney brand from long-term partner

* Derma sciences buys Medihoney brand from long-term partner

BRIEF-Integra Lifesciences says upon termination of merger agreement under specified circumstances, Derma required to pay co termination fee $6.12 million - SEC filing

* Integra Lifesciences says upon termination of merger agreement under specified circumstances, Derma required to pay co termination fee $6.12 million - SEC filing Source text for Eikon: Further company coverage:

BRIEF-Integra lifesciences sees FY 2017 adj shr $1.91 to $1.97

* Integra Lifesciences Holdings - expects Q4 2016 gaap and adjusted diluted EPS to be at or above mid-point of prior guidance range of $0.32 to $0.35 and $0.50 to $0.53 respectively

BRIEF-Integra Lifesciences to buy Derma Sciences

* Derma Sciences to be acquired by Integra Lifesciences for $7.00 per share of common stock in cash

BRIEF-Derma Sciences Q3 loss per share $0.05

* Derma sciences reports 2016 third quarter financial results

BRIEF-Derma Sciences gets reimbursement coding for medihoney hydrogel dressings

* Derma Sciences receives reimbursement coding for new Medihoney Hydrogel dressings

Select another date:

More From Around the Web